Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Non-cash Items: 2015-2022

Historic Non-cash Items for Editas Medicine (EDIT) over the last 8 years, with Dec 2022 value amounting to $401.5 million.

  • Editas Medicine's Non-cash Items fell 99.76% to $2.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was $2.6 million, marking a year-over-year decrease of 99.76%. This contributed to the annual value of $401.5 million for FY2022, which is 92.05% down from last year.
  • Per Editas Medicine's latest filing, its Non-cash Items stood at $401.5 million for FY2022, which was down 92.05% from $5.1 billion recorded in FY2021.
  • Editas Medicine's Non-cash Items' 5-year high stood at $5.1 billion during FY2021, with a 5-year trough of $1.5 million in FY2020.
  • For the 3-year period, Editas Medicine's Non-cash Items averaged around $1.8 billion, with its median value being $401.5 million (2022).
  • As far as peak fluctuations go, Editas Medicine's Non-cash Items tumbled by 96.60% in 2018, and later spiked by 345,092.28% in 2021.
  • Over the past 5 years, Editas Medicine's Non-cash Items (Yearly) stood at $2.1 million in 2018, then fell by 3.27% to $2.0 million in 2019, then declined by 26.61% to $1.5 million in 2020, then skyrocketed by 345,092.28% to $5.1 billion in 2021, then tumbled by 92.05% to $401.5 million in 2022.